Similar Search Results

Comanor, William S. - 2013

industry, which is regarded as the future for pharmaceuticals. Further sections discuss topics including demand and incentives … including biosimilars, insurance coverage for pharmaceuticals, price-fixing and direct-to-consumer advertising. An authoritative … and the Pricing of Pharmaceuticals', Journal of Economics and Management Strategy, 6 (1), Spring, 75-90 -- Steven …

Persistent link: https://www.econbiz.de/10011852149

Innovation in the pharmaceutical industry : the process of drug discovery and development

Hara, Takuji - 2003

Innovation in the Pharmaceutical Industry traces the discovery and development of drugs in Japan and the UK both historically and sociologically. It includes sixteen case studies of major pharmaceutical developments in the twentieth century, encompassing, amongst others, beta-blockers,...

Persistent link: https://www.econbiz.de/10011851006

Brand protection and the global risk of product counterfeits : a total business solution approach

Wilson, Jeremy M. (ed.) - 2022

"Product counterfeits and other brand infringements represent a growing and substantial risk to firms, consumers, and society. While policing such illicit activity is important, there is much that firms can do to protect themselves and their customers. Grounded in field research and practice,...

Persistent link: https://www.econbiz.de/10013400359

Competition policies and consumer welfare : corporate strategies and consumer prices in developing countries

Achy, Lahcen (contributor); Joekes, Susan P. (contributor) - 2016

-- Section II the distribution of pharmaceuticals -- 6. Jamaica -- 7. Vietnam -- Section III the distribution of services …

Persistent link: https://www.econbiz.de/10012419893

Innovation and commercialisation in the biopharmaceutical industry : creating and capturing value

Rasmussen, Bruce - 2010

This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the...

Persistent link: https://www.econbiz.de/10011851419

The public financing of pharmaceuticals : an economic approach

Puig-Junoy, Jaume (contributor) - 2005

. Reference pricing as a pharmaceutical reimbursement mechanism -- 7. Insurance in public financing of pharmaceuticals -- 8 …

Persistent link: https://www.econbiz.de/10011851613

Industries in Europe : competition, trends, and policy issues

Johnson, P. S. (contributor) - 2003 - 2nd ed

-- 6. Pharmaceuticals -- 7. Biotechnology -- 8. Metals -- 9. Motor vehicles -- 10. Air transport -- 11. Financial services …

Persistent link: https://www.econbiz.de/10011851763

Intellectual property rights and the financing of technological innovation : public policy and the efficiency of capital markets

Frey, Carl Benedikt - 2013

1. Introduction -- 2. The intangible economy -- 3. Patent information and corporate credit ratings : an empirical study of patent valuation by credit rating agencies -- 4. IPR management and company valuation in the pharmaceutical industry : an exploratory study -- 5. IPR management, corporate...

Persistent link: https://www.econbiz.de/10012420126

Japanese multinationals in Europe : a comparison of the automobile and pharmaceutical industries

Andō, Kenʼichi - 2005

This book explores the regional strategy and management of Japanese MNEs in Europe. Ken-ichi Ando investigates, using case studies of the auto and pharmaceutical industries, how these companies can, and do, overcome the inherent difficulties and opportunities of trading in Europe, including the...

Persistent link: https://www.econbiz.de/10014473794

The political economy of HIV/AIDS in developing countries : TRIPS, public health systems, and free access

Coriat, Benjamin (contributor) - 2008

The book is based on original data and field studies from Brazil, Thailand, India and Sub-Saharan Africa. Focusing on the issue of universal and free access to treatment (a goal now taken to heart by the international community), it assesses the progress made and presents a rigorous diagnosis of...

Persistent link: https://www.econbiz.de/10011850669